References
- Cheng G, Zhao Y, Li H, Wu Y, Li X, Han Q, Dai C, Li Y. 2014. Forsythiaside attenuates lipopolysaccharide-induced inflammatory responses in the bursa of Fabricius of chickens by downregulating the NF-κB signaling pathway. Exp Ther Med. 7:179–184.10.3892/etm.2013.1378
- Cui Y, Wang Q, Shi X, Zhang X, Sheng X, Zhang L. 2010. Simultaneous quantification of 14 bioactive constituents in Forsythia Suspensa by liquid chromatography-electrospray ionisation-mass spectrometry. Phytochem Anal. 21:253–260.10.1002/pca.v21:3
- Delgado M, Ganea D. 2003. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson’s disease by blocking microglial activation. FASEB J. 17:944–946.
- Gao HM, Hong JS, Zhang W, Liu B. 2002. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 22:782–790.
- Ge Y, Wang Y, Chen P, Wang Y, Hou C, Wu Y, Zhang M, Li L, Huo C, Shi Q, et al. 2016. Polyhydroxytriterpenoids and phenolic constituents from Forsythia suspensa (Thunb.) Vahl leaves. J Agric Food Chem. 64:125–131.10.1021/acs.jafc.5b04509
- Gu Q, Li Y, Chen Y, Yao P, Ou T. 2013. Sciadopitysin: active component from Taxus chinensis for anti-Alzheimer’s disease. Nat Prod Res. 27:2157–2160.10.1080/14786419.2013.790031
- Han Z, Lei XL, Zhang H, Liu L, Chen ZS, Yang W, Lun ZR. 2017. Evaluating the safety of forsythin from Forsythia suspensa leaves by acute and sub-chronic oral administration in rodent models. Asian Pac J Trop Med. 10:47–51.10.1016/j.apjtm.2016.10.011
- Kang HS, Lee JY, Kim CJ. 2008. Anti-inflammatory activity of arctigenin from Forsythiae Fructus. J Ethnopharmacol. 116:305–312.10.1016/j.jep.2007.11.030
- Kim S, Kim DH, Choi JJ, Lee JG, Lee CH, Park SJ, Jung WY, Park DH, Ko KH, Lee SH, et al. 2009. Forsythiaside, a constituent of the fruits of Forsythia suspensa, ameliorates scopolamine-induced memory impairment in mice. Biomol Ther. 17:249–255.10.4062/biomolther.2009.17.3.249
- Kim JM, Kim S, Kim DH, Lee CH, Park SJ, Jung JW, Ko KH, Cheong JH, Lee SH, Ryu JH. 2011. Neuroprotective effect of forsythiaside against transient cerebral global ischemia in gerbil. Eur J Pharmacol. 660:326–333.10.1016/j.ejphar.2011.03.051
- Morimoto K, Satake H. 2013. Seasonal alteration in amounts of lignans and their glucosides and gene expression of the relevant biosynthetic enzymes in the Forsythia suspensa leaf. Biol Pharm Bull. 36:1519–1523.10.1248/bpb.b13-00437
- Qu H, Li B, Li X, Tu G, Lü J, Sun W. 2008. Qualitative and quantitative analyses of three bioactive compounds in different parts of Forsythia suspensa by high-performance liquid chromatography-electrospray ionization-mass spectrometry. Microchem J. 89:159–164.10.1016/j.microc.2008.02.002
- Ravi SK, Narasingappa RB, Joshi CG, Girish TK, Vincent B. 2017. Neuroprotective effects of Cassia tora against paraquat induced neurodegeneration: relevance for Parkinson’s disease. Nat Prod Res. 2:1–5.10.1080/14786419.2017.1353504
- Wang HM, Wang LW, Liu XM, Li CL, Xu SP, Farooq AD. 2013. Neuroprotective effects of forsythiaside on learning and memory deficits in senescence-accelerated mouse prone (SAMP8) mice. Pharmacol Biochem Behav. 105:134–141.10.1016/j.pbb.2012.12.016
- [CPH] Chinese Pharmacopoeia Commission. 2015. Pharmacopoeia of the people’s republic of china. Part One. China Medical Science Press; p. 170–171.
- Yan X, Chen T, Zhang L, Du H. 2017. Protective effects of Forsythoside A on amyloid beta-induced apoptosis in PC12 cells by downregulating acetylcholinesterase. Eur J Pharmacol. 810:141–148.10.1016/j.ejphar.2017.07.009
- Yuan JF, Liu XQ, Yang JX, Cui XQ. 2014. Forsythia suspense leaves, a plant: extraction, purification and antioxidant activity of main active compounds. Eur Food Res Technol. 238:527–533.10.1007/s00217-014-2179-y
- Zhang Q, Lu Z, Li X, Zheng Y, Yao D, Gu Y, Huo C, Cong B. 2015. Triterpenoids and steroids from the leaves of Forsythia suspense. Chem Nat Compd. 51:178–180.10.1007/s10600-015-1236-5